• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光辉霉素A可抑制肺癌细胞的DNA甲基转移酶和转移潜能。

Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells.

作者信息

Lin Ruo-Kai, Hsu Chun-Hua, Wang Yi-Ching

机构信息

Department of Life Sciences, National Taiwan Normal University, Taipei, Taiwan, ROC.

出版信息

Anticancer Drugs. 2007 Nov;18(10):1157-64. doi: 10.1097/CAD.0b013e3282a215e9.

DOI:10.1097/CAD.0b013e3282a215e9
PMID:17893516
Abstract

Abnormal CpG island hypermethylation of multiple tumor-suppressor genes (TSGs) can lead to the initiation and progression of human cancer. The cytosine of the CpG island on the promoter region is methylated by 5'-cytosine-methyltransferases (DNMTs). Pharmacologic inhibitors of CpG island methylation provide a rational approach to reactivate the TSGs in tumor cells and to restore the critical cellular pathways in cancer cells. Mithramycin A (MMA) is known to be a GC- and CG-rich DNA-binding agent. We sought to determine whether MMA could inhibit CpG island methylation and DNMT expression in lung cancer cells. We found that MMA reduced the CpG island methylation of antimetastasis TSGs, including SLIT2 and TIMP-3 genes, and was associated with the prevention of metastasis. When highly metastatic CL1-5 lung cancer cells were treated with low doses (10 nmol/l) of MMA for 14 days, they reexpressed mRNA levels for these genes. MMA also inhibited the invasion phenotypes of CL1-5 cells as indicated by its inhibition of cancer cell migration using wound-healing and transwell assays. Molecular docking of MMA onto the DNMT1 catalytic domain revealed that MMA might interact with the catalytic pocket of DNMT1. Western blots showed that DNMT1 protein levels were depleted after MMA. These data support the idea that MMA has demethylation and antimetastasis effects on lung cancer cells. This mechanism might be mediated by the interaction of MMA and DNMT1, leading to the depletion of the DNMT1 protein and the reversal of the metastasis phenotype in lung cancer cells.

摘要

多个肿瘤抑制基因(TSG)的异常CpG岛高甲基化可导致人类癌症的发生和发展。启动子区域CpG岛的胞嘧啶由5'-胞嘧啶甲基转移酶(DNMT)甲基化。CpG岛甲基化的药理抑制剂为重新激活肿瘤细胞中的TSG以及恢复癌细胞中的关键细胞通路提供了一种合理的方法。光辉霉素A(MMA)是一种已知的富含GC和CG的DNA结合剂。我们试图确定MMA是否能抑制肺癌细胞中的CpG岛甲基化和DNMT表达。我们发现MMA降低了包括SLIT2和TIMP-3基因在内的抗转移TSG的CpG岛甲基化,并与转移的预防有关。当高转移性CL1-5肺癌细胞用低剂量(10 nmol/l)的MMA处理14天时,它们重新表达了这些基因的mRNA水平。MMA还抑制了CL1-5细胞的侵袭表型,这通过其使用伤口愈合和transwell试验对癌细胞迁移的抑制来表明。MMA与DNMT1催化结构域的分子对接显示,MMA可能与DNMT1的催化口袋相互作用。蛋白质免疫印迹显示,MMA处理后DNMT1蛋白水平降低。这些数据支持了MMA对肺癌细胞具有去甲基化和抗转移作用的观点。这种机制可能是由MMA与DNMT1的相互作用介导的,导致DNMT1蛋白的消耗以及肺癌细胞转移表型的逆转。

相似文献

1
Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells.光辉霉素A可抑制肺癌细胞的DNA甲基转移酶和转移潜能。
Anticancer Drugs. 2007 Nov;18(10):1157-64. doi: 10.1097/CAD.0b013e3282a215e9.
2
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.在人类癌细胞中,维持CpG甲基化和异常基因沉默需要DNMT1。
Nat Genet. 2003 Jan;33(1):61-5. doi: 10.1038/ng1068. Epub 2002 Dec 23.
3
De novo CpG island methylation in human cancer cells.人类癌细胞中的从头CpG岛甲基化
Cancer Res. 2006 Jan 15;66(2):682-92. doi: 10.1158/0008-5472.CAN-05-1980.
4
Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.DNA甲基转移酶-1的mRNA水平升高作为原发性非小细胞肺癌的独立预后因素。
Cancer. 2006 Sep 1;107(5):1042-9. doi: 10.1002/cncr.22087.
5
CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1.在RNA干扰介导的DNMT1缺失后,人结肠癌细胞中CpG岛的高甲基化状态得以维持。
Nat Genet. 2004 Jun;36(6):582-4. doi: 10.1038/ng1365. Epub 2004 May 23.
6
Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.DNA甲基转移酶的改变导致肺癌中5'CpG甲基化及预后不良。
Lung Cancer. 2007 Feb;55(2):205-13. doi: 10.1016/j.lungcan.2006.10.022. Epub 2006 Nov 30.
7
Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.RAS癌基因导致的甲基化及尿激酶型纤溶酶原激活物表达抑制:乳腺癌细胞生长控制与侵袭的差异
Carcinogenesis. 2005 Mar;26(3):557-64. doi: 10.1093/carcin/bgi009. Epub 2004 Dec 23.
8
The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA.小鼠DNA甲基转移酶Dnmt1的活性受催化结构域与该酶N端部分相互作用的调控,这种相互作用导致该酶在与甲基化DNA结合后发生变构激活。
J Mol Biol. 2001 Jun 22;309(5):1189-99. doi: 10.1006/jmbi.2001.4709.
9
DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.黏液表皮样癌中DNA甲基转移酶1的表达及E-钙黏蛋白的启动子甲基化
Cancer. 2005 Sep 1;104(5):1013-21. doi: 10.1002/cncr.21278.
10
DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.在多阶段尿路上皮癌发生过程中,多个CpG岛的DNA高甲基化与DNA甲基转移酶DNMT1蛋白表达增加相关。
J Urol. 2005 May;173(5):1767-71. doi: 10.1097/01.ju.0000154632.11824.4d.

引用本文的文献

1
The Hypomethylating Agent 5-Azacitidine Potentiates the Effect of RAS and Sp1 Inhibitors in Neuroblastoma Cells.低甲基化剂5-氮杂胞苷增强RAS和Sp1抑制剂对神经母细胞瘤细胞的作用。
Acta Naturae. 2025 Apr-Jun;17(2):86-97. doi: 10.32607/actanaturae.27558.
2
The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC).DNA甲基化和DNA甲基转移酶(DNMTs)在非小细胞肺癌(NSCLC)中作为潜在生物标志物和治疗靶点的作用。
Heliyon. 2024 Sep 27;10(19):e38663. doi: 10.1016/j.heliyon.2024.e38663. eCollection 2024 Oct 15.
3
ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.
ELK4 通过非经典的 SP1/3 依赖性方式激活新生血管因子 LRG1 促进结直肠癌进展。
Adv Sci (Weinh). 2023 Nov;10(32):e2303378. doi: 10.1002/advs.202303378. Epub 2023 Oct 2.
4
Recent progress in DNA methyltransferase inhibitors as anticancer agents.DNA甲基转移酶抑制剂作为抗癌药物的最新进展。
Front Pharmacol. 2022 Dec 16;13:1072651. doi: 10.3389/fphar.2022.1072651. eCollection 2022.
5
Disruption of nucleosomes by DNA groove binders of clinical significance and implications for chromatin remodeling.具有临床意义的 DNA 沟结合物对核小体的破坏作用及其对染色质重塑的影响。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2216611120. doi: 10.1073/pnas.2216611120. Epub 2022 Dec 27.
6
Differential Impact of Random GC Tetrad Binding and Chromatin Events on Transcriptional Inhibition by Olivomycin A.随机 GC 四联体结合和染色质事件对橄榄霉素 A 转录抑制的差异影响。
Int J Mol Sci. 2022 Aug 9;23(16):8871. doi: 10.3390/ijms23168871.
7
Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer.表观遗传学改变与炎症作为非小细胞肺癌治疗进展的新用途。
Front Immunol. 2022 Apr 20;13:878740. doi: 10.3389/fimmu.2022.878740. eCollection 2022.
8
Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development.靶向表观遗传调控酶用于癌症治疗:新型小分子表观遗传药物的开发。
Front Oncol. 2022 Mar 28;12:848221. doi: 10.3389/fonc.2022.848221. eCollection 2022.
9
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model.米托蒽醌联合免疫检查点抑制剂治疗荷瘤小鼠结直肠癌的实验研究。
Front Immunol. 2021 Jul 26;12:706133. doi: 10.3389/fimmu.2021.706133. eCollection 2021.
10
Emerging epigenetic targets in rheumatoid arthritis.类风湿关节炎中新兴的表观遗传学靶点。
Rheumatol Int. 2021 Dec;41(12):2047-2067. doi: 10.1007/s00296-021-04951-y. Epub 2021 Jul 26.